Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-07-03-Speech-2-586-000"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20120703.23.2-586-000"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"Mr President, we are going from one heated debate, ACTA, to another heated debate, ACAA. Time and again, we have been postponing and obstructing the ACAA, using different filibusters and trying to do everything we cannot to do what we know is needed. The only consequence is that we are postponing something that would help patients in Europe, that would give more choice in terms of medicines, and that would deliver greater competition and lower prices, even though everybody here knows it is about standards and that there are no medicines produced in the occupied territories. So how could this question even be relevant in this context? Even if there were medicines produced there, you know that these standards should apply to Israeli-produced medicines and to imported medicines, no matter where they come from.
The Israeli Government has a clear commitment to applying these standards. That is what it is all about. But sadly, this House has managed to hijack this question and make it into another part of the Israeli-Palestinian conflict to the detriment of patients throughout Europe. That is a shame. Remember that we had an agreement and a debate on an agreement with Palestine – quite recently actually – and, at that time, we had the courage not to do what we are doing here. We judged it on its own merits and approved it. We should do the same thing right here and right now."@en1
|
lpv:unclassifiedMetadata |
"Christofer Fjellner (PPE )."1
|
lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples